systemic mastocytosis: current treatments and emerging targeted agents
Published 1 year ago • 2.2K plays • Length 5:21Download video MP4
Download video MP3
Similar videos
-
1:44
emerging novel agents for the treatment of mastocytosis
-
0:37
emerging targeted agents in the field of mastocytosis
-
1:23
the current treatment landscape for indolent systemic mastocytosis
-
2:56
insights into the treatment and management of advanced systemic mastocytosis
-
2:37
current approaches to treating systemic mastocytosis
-
12:30
ask experts in nonadvanced systemic mastocytosis
-
12:11
indolent mastocytosis
-
5:16
is it systemic mastocytosis? best practices for diagnosis and management – patient video
-
2:14
diagnosis, classification and treatment of systemic mastocytosis
-
4:46
management strategies for advanced systemic mastocytosis
-
1:41
the current therapeutic landscape for indolent and advanced systemic mastocytosis
-
1:45
the recent updates to the nccn guidelines for systemic mastocytosis
-
1:46
updated analyses from the pathfinder trial: avapritinib therapy in advanced systemic mastocytosis
-
4:58
results from the touchstone survey of systemic mastocytosis patients and their healthcare providers
-
2:03
the safety and efficacy of avapritinib in patients with advanced systemic mastocytosis
-
1:28
developments in the mastocytosis field at ash 2020
-
1:46
unmet needs and challenges in advanced systemic mastocytosis
-
9:29
pioneer: avapritinib in patients with indolent systemic mastocytosis
-
3:05
explorer: avapritinib in systemic mastocytosis
-
1:20
the current standard of care for patients with lower-risk mds
-
1:50
unmet needs and challenges in mastocytosis
-
2:15
areas of unmet need in patients with mastocytosis